Palmqvist, Sebastian
Schöll, Michael http://orcid.org/0000-0001-7800-1781
Strandberg, Olof
Mattsson, Niklas
Stomrud, Erik
Zetterberg, Henrik
Blennow, Kaj
Landau, Susan
Jagust, William
Hansson, Oskar
Article History
Received: 3 January 2017
Accepted: 23 August 2017
First Online: 31 October 2017
Competing interests
: S.P., M.S., O.S., N.M., and E.S. report no competing financial interests. K.B. has served as a consultant or at advisory boards for Alzheon, Eli Lilly, Fujirebio Europe, I.B.L. International, Novartis, and Roche Diagnostics. K.B. and H.Z. are co-founders of Brain Biomarker Solutions in Gothenburg AB, a GU Venture-based platform company at the University of Gothenburg. S.L. has consulted for Biogen, Synarc, and Genentech. W.J. serves as a consultant to Bioclinica, Genentech, and Novartis pharmaceuticals. O.H. has acquired research support (for the institution) from Roche, GE Healthcare, Biogen, AVID Radiopharmaceuticals, Fujirebio, and Euroimmun and in the past 2 years, he has received consultancy or speaker fees (paid to the institution) from Lilly, Roche, and Fujirebio. <sup>18</sup>F-flutemetamol was generously provided by GE Healthcare in the BioFINDER study.